ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I-IV clinical studies.
In a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis.
We have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full service” solution.
The ultimate investigator training and support system
As clinical trials become more complex, an increasing burden is being placed on investigators who have to deal with the frequent protocol amendments, more complex procedures and an ever expanding case report form. Ineffective training, inadequate communications and poor data capture methods contribute to poor trial performances which inevitably result in delayed recruitment, frequent non-compliances with protocols and ultimately, delayed study close-out and market approval.